These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


239 related items for PubMed ID: 14769091

  • 1. Intra-administration associations and withdrawal symptoms: morphine-elicited morphine withdrawal.
    McDonald RV, Siegel S.
    Exp Clin Psychopharmacol; 2004 Feb; 12(1):3-11. PubMed ID: 14769091
    [Abstract] [Full Text] [Related]

  • 2. Intraadministration associations: conditional hyperalgesia elicited by morphine onset cues.
    Sokolowska M, Siegel S, Kim JA.
    J Exp Psychol Anim Behav Process; 2002 Jul; 28(3):309-20. PubMed ID: 12136706
    [Abstract] [Full Text] [Related]

  • 3. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
    Pinelli A, Cighetti G, Trivulzio S.
    Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
    [Abstract] [Full Text] [Related]

  • 4. Morphine blocks and naloxone enhances suppression of operant behavior by low doses of 3-isobutyl-1-methylxanthine.
    Kleven MS, Sparber SB.
    J Pharmacol Exp Ther; 1989 Jan; 248(1):273-7. PubMed ID: 2464058
    [Abstract] [Full Text] [Related]

  • 5. Disentangling the sources of opioid withdrawal responses: comment on McDonald and Siegel (2004).
    Stewart J.
    Exp Clin Psychopharmacol; 2004 Feb; 12(1):20-2; discussion 23-6. PubMed ID: 14769095
    [Abstract] [Full Text] [Related]

  • 6. Morphine withdrawal-facilitated aggression is attenuated by morphine-conditioned stimuli.
    Sukhotina IA.
    Pharmacol Biochem Behav; 2001 Jan; 68(1):93-8. PubMed ID: 11274713
    [Abstract] [Full Text] [Related]

  • 7. The behavioral effects of chlorpromazine alone and in combination with different morphine treatments in rats.
    Lucot JB, McMillan DE, Leander JD.
    J Pharmacol Exp Ther; 1979 Jan; 208(1):67-72. PubMed ID: 569698
    [No Abstract] [Full Text] [Related]

  • 8. Drug onset cues, conditioned withdrawal, and drug relapse: comment on McDonald and Siegel (2004).
    Bossert JM, Shaham Y.
    Exp Clin Psychopharmacol; 2004 Feb; 12(1):15-7; discussion 23-6. PubMed ID: 14769093
    [Abstract] [Full Text] [Related]

  • 9. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
    Jin C, Araki H, Nagata M, Shimosaka R, Shibata K, Suemaru K, Kawasaki H, Gomita Y.
    Behav Brain Res; 2005 Jun 03; 161(1):107-12. PubMed ID: 15904717
    [Abstract] [Full Text] [Related]

  • 10. The behavioral effects of d-amphetamine alone and in combination with acute and chronic morphine treatments in rats.
    Lucot JB, McMillan DE, Leander JD.
    J Pharmacol Exp Ther; 1979 Aug 03; 210(2):158-65. PubMed ID: 572418
    [No Abstract] [Full Text] [Related]

  • 11. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S, Göktalay G, Millington WR.
    J Pharmacol Exp Ther; 2005 Nov 03; 315(2):949-58. PubMed ID: 16079299
    [Abstract] [Full Text] [Related]

  • 12. Drug-onset cues as signals: intraadministration associations and tolerance.
    Kim JA, Siegel S, Patenall VR.
    J Exp Psychol Anim Behav Process; 1999 Oct 03; 25(4):491-504. PubMed ID: 10531660
    [Abstract] [Full Text] [Related]

  • 13. Dynamic changes in orbitofrontal neuronal activity in rats during opiate administration and withdrawal.
    Sun N, Li Y, Tian S, Lei Y, Zheng J, Yang J, Sui N, Xu L, Pei G, Wilson FA, Ma Y, Lei H, Hu X.
    Neuroscience; 2006 Oct 03; 138(1):77-82. PubMed ID: 16377092
    [Abstract] [Full Text] [Related]

  • 14. Effects of narcotics and narcotic antagonists on operant behavior.
    McMillan DE.
    Adv Biochem Psychopharmacol; 1973 Oct 03; 8(0):345-59. PubMed ID: 4604406
    [No Abstract] [Full Text] [Related]

  • 15. Repeated pre-exposure to morphine into the ventral pallidum enhances morphine-induced place preference: involvement of dopaminergic and opioidergic mechanisms.
    Zarrindast MR, Ebrahimi-Ghiri M, Rostami P, Rezayof A.
    Behav Brain Res; 2007 Jul 19; 181(1):35-41. PubMed ID: 17451818
    [Abstract] [Full Text] [Related]

  • 16. GABA(A) receptors of hippocampal CA1 regions are involved in the acquisition and expression of morphine-induced place preference.
    Rezayof A, Razavi S, Haeri-Rohani A, Rassouli Y, Zarrindast MR.
    Eur Neuropsychopharmacol; 2007 Jan 19; 17(1):24-31. PubMed ID: 16624534
    [Abstract] [Full Text] [Related]

  • 17. A comparison between spontaneous electroencephalographic activities induced by morphine and morphine-related environment in rats.
    Zuo YF, Wang JY, Chen JH, Qiao ZM, Han JS, Cui CL, Luo F.
    Brain Res; 2007 Mar 09; 1136(1):88-101. PubMed ID: 17234161
    [Abstract] [Full Text] [Related]

  • 18. The dopamine release inhibitor CGS 10746B blocks conditioned physical signs of morphine withdrawal.
    Rodríguez-Arias M, Aguilar MA, Miñarro J.
    Addict Biol; 2003 Jun 09; 8(2):167-72. PubMed ID: 12850775
    [Abstract] [Full Text] [Related]

  • 19. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine.
    Cabral A, Ruggiero RN, Nobre MJ, Brandão ML, Castilho VM.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar 17; 33(2):334-44. PubMed ID: 19150477
    [Abstract] [Full Text] [Related]

  • 20. Gender- and morphine dose-linked expression of spontaneous somatic opiate withdrawal in mice.
    Papaleo F, Contarino A.
    Behav Brain Res; 2006 Jun 03; 170(1):110-8. PubMed ID: 16580078
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.